3SBio Inc., of Shenyang, China, appointed Zhenping Zhu president of research and development and chief scientific officer. Zhu has extensive R&D experience in the biotechnology industry. Prior to joining 3SBio, he served as executive vice president, global biopharmaceuticals for Kadmon Corp., and president of Kadmon China.